Literature DB >> 15219580

Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans.

Andrew H Kemp1, Marcus A Gray, Richard B Silberstein, Stuart M Armstrong, Pradeep J Nathan.   

Abstract

The serotonergic system is one of the major systems targeted in the pharmacological treatment of a wide range of mood disorders including depression; however, little is known about the neurophysiological mechanisms underlying the effects of serotonin (5-HT) on affective phenomena including emotional behaviours, mood and emotional processing. The aim of the current study was to investigate how 5-HT acutely modulates steady-state visually evoked potentials (SSVEP), heart rate (HR) and verbal ratings associated with the viewing of differently valent emotional images. In a randomised double-blind, placebo-controlled design, 17 healthy subjects were tested under two acute treatment conditions: placebo and citalopram (20 mg) (a selective serotonin re-uptake inhibitor, or SSRI). Participants were tested 2 h post treatment whilst viewing 75 images (categorised as pleasant, neutral or unpleasant). Results indicate that under placebo treatment, processing of unpleasant valence [unpleasant (-) neutral images] was associated with decreases in SSVEP amplitude and latency in frontal and occipital cortices, whereas processing of pleasant valence [pleasant (-) neutral images] was associated with amplitude decreases and latency increases within frontal and left temporoparietal cortices. Decreases in both amplitude and latency are both interpreted as surrogate measures of cortical activation or excitation. Citalopram relative to placebo attenuated the electrophysiological activation to unpleasant valence within frontal and occipital cortices, but potentiated electrophysiological activation (amplitude only) to pleasant valence within parietooccipital cortices. Citalopram relative to placebo also suppressed differences in heart rate associated with the viewing of pleasant and unpleasant images, but did not alter subject's subjective responses to emotional images. Results suggest that responsiveness to pleasant and unpleasant stimuli following neurochemical modulation may vary across different response systems (i.e. self-report, HR and SSVEP). Electrophysiological findings suggest that acute serotonergic augmentation with citalopram modulates cortical processing of emotionally valent stimuli such that response to pleasant valence is potentiated and response to unpleasant valence is suppressed. The findings suggest a possible neurophysiological mechanism underlying antidepressant drug action on emotion. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219580     DOI: 10.1016/j.neuroimage.2004.03.022

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  25 in total

1.  Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects.

Authors:  Andrew H Kemp; Tim Outhred; Sasha Saunders; Andre R Brunoni; Pradeep J Nathan; Gin S Malhi
Journal:  Psychopharmacology (Berl)       Date:  2013-12-15       Impact factor: 4.530

2.  Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients.

Authors:  E Fakra; S Khalfa; D Da Fonseca; N Besnier; P Delaveau; J M Azorin; O Blin
Journal:  Psychopharmacology (Berl)       Date:  2008-06-25       Impact factor: 4.530

3.  Amplitude modulation of steady-state visual evoked potentials by event-related potentials in a working memory task.

Authors:  Zhenghua Wu; Dezhong Yao; Yu Tang; Yilan Huang; Sheng Su
Journal:  J Biol Phys       Date:  2009-12-04       Impact factor: 1.365

4.  Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.

Authors:  Christian Grillon; Chanen Chavis; Matthew F Covington; Daniel S Pine
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

5.  Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.

Authors:  Christian Grillon; Randi Heller; Elizabeth Hirschhorn; Mitchel A Kling; Daniel S Pine; Jay Schulkin; Meena Vythilingam
Journal:  Biol Psychiatry       Date:  2011-01-31       Impact factor: 13.382

6.  Studying modulation on simultaneously activated SSVEP neural networks by a cognitive task.

Authors:  Zhenghua Wu
Journal:  J Biol Phys       Date:  2014-01-13       Impact factor: 1.365

7.  Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.

Authors:  Rebecca Kerestes; Izelle Labuschagne; Rodney J Croft; Barry V O'Neill; Zubin Bhagwagar; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2008-09-30       Impact factor: 4.530

8.  Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder.

Authors:  Christian Grillon; Shmuel Lissek; Stephanie Rabin; Dana McDowell; Sharone Dvir; Daniel S Pine
Journal:  Am J Psychiatry       Date:  2008-03-17       Impact factor: 18.112

9.  Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder.

Authors:  Christian Grillon; Daniel S Pine; Shmuel Lissek; Stephanie Rabin; Omer Bonne; Meena Vythilingam
Journal:  Biol Psychiatry       Date:  2009-02-12       Impact factor: 13.382

10.  Re-entrant projections modulate visual cortex in affective perception: evidence from Granger causality analysis.

Authors:  Andreas Keil; Dean Sabatinelli; Mingzhou Ding; Peter J Lang; Niklas Ihssen; Sabine Heim
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.